If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.40
Bid: 135.00
Ask: 135.40
Change: 4.20 (3.20%)
Spread: 0.40 (0.296%)
Open: 131.60
High: 135.40
Low: 130.20
Prev. Close: 131.20
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update; strategic review initiated

21 Feb 2017 16:16

RNS Number : 4732X
NCC Group PLC
21 February 2017
 

21 February 2017

 

NCC Group plc

 

Trading update, strategic review initiated and Capital Markets Day cancelled

 

NCC Group plc (LSE: NCC, "NCC Group" or "the Group"), the independent global cyber security and risk mitigation expert, has published a trading update and initiated a strategic review. As a result, the Group has cancelled the Capital Markets Day due to take place on Wednesday 22 February 2017.

 

Trading update

 

The Board has reviewed its third quarter performance to date and the expected financial outcome for the full year ending 31 May 2017. As a result of this review, the Board has concluded that the performance of the Assurance Division will be significantly lower than previously anticipated.

 

The Board now anticipates that the Group's full year adjusted[i] EBITDA will be approximately 20% below the £45.5m to £47.5m range, which it published in the trading update announcement on 13th December 2016.

 

The rate of sales growth and subsequent delivery in the Assurance Division in the third quarter to date has been lower than had been anticipated in both Security Consulting and Software Testing and Web Performance. The reduction in expected sales and profitability in the third quarter has been seen in the UK, mainland Europe and North America.

 

Whilst sales levels are traditionally significantly higher in the fourth quarter, they are unlikely to utilise fully the cost base deployed across the Assurance Division in the current financial year. This will reduce the Division's profitability in the final quarter.

 

The Escrow Division continues to perform in line with expectations.

 

Review of strategy

 

In light of the deterioration in trading in the Assurance Division through the current financial year, the Board is initiating a comprehensive review of NCC Group's operating strategy. This will include a review of all of the Assurance businesses, how they operate and how they sell.

 

In addition, given that the significant and planned rise in central and divisional operating costs this financial year has not produced the anticipated improvement in sales, there will also be a review of how the assets and resources of the Group can be more efficiently deployed and utilised.

 

The review will be led by the Board, supported by externally appointed consultants. The Board expects to update the market no later than the Preliminary Results, due to be announced in July 2017.

 

The Escrow Division continues to perform satisfactorily. NCC Group continues to firmly believe that the Assurance Division has significant growth prospects which it is determined to capture once the Group has reviewed its existing strategy and operations.

 

Cancellation of Capital Markets Day

 

As a consequence of this announcement, NCC Group has cancelled the Capital Markets Day planned for tomorrow, 22 February, 2017.

 

 

Enquiries:

 

NCC Group (www.nccgroup.trust)

+44 (0)161 209 5432

Rob Cotton, Chief Executive

Brian Tenner, Chief Financial Officer

Instinctif Partners

Adrian Duffield/Lauren Foster

+44 (0)20 7457 2020

 

 

 


[i] Adjusted figures exclude the impact of exceptional items, the results of the now closed Domain Services business, share based payments, unwinding of discount on deferred consideration and amortization of acquired intangible assets and any associated tax thereon.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQFLFLDLFFBBE
Date   Source Headline
2nd May 20247:00 amRNSCapital Markets Event for CSMS
1st May 20248:16 amRNSDirector Declaration
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.